Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Akero Therapeutics, Inc. (AKRO) Receiveable Turnover data is not available.
| Income Statement Financials | |
-- |
|
$-151.76M |
|
-- |
|
-- |
|
$172.87M |
|
$-172.87M |
|
$21.11M |
|
$-151.76M |
|
$-151.76M |
|
$-151.76M |
|
$-151.76M |
|
$-151.76M |
|
$-151.76M |
|
$-172.87M |
|
$-181.95M |
|
52.57M |
|
52.57M |
|
$-2.89 |
|
$-2.89 |
|
| Balance Sheet Financials | |
$559.96M |
|
$0.02M |
|
$20.31M |
|
$580.27M |
|
$19.13M |
|
$25.02M |
|
$25.84M |
|
$44.97M |
|
$535.31M |
|
$535.31M |
|
$535.31M |
|
55.75M |
|
| Cash Flow Statement Financials | |
$-145.37M |
|
$-223.62M |
|
$353.32M |
|
$249.88M |
|
$234.21M |
|
$-15.67M |
|
$21.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
29.27 |
|
-- |
|
-- |
|
0.04 |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-145.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-28.35% |
|
-28.35% |
|
-26.15% |
|
-27.08% |
|
$9.60 |
|
$-2.77 |
|
$-2.77 |
|